Westhuyzen J, Matherson K, Tracey R, Fleming S J
Conjoint Renal Laboratory, Royal Brisbane Hospital, Australia.
Clin Nephrol. 1993 Aug;40(2):96-9.
The requirement of patients on maintenance hemodialysis for dietary supplements of folic acid is controversial. High levels of folate carry the risk of toxicity as well as being unnecessary. We followed a group of 41 patients, not receiving erythropoietin, for 16 months after the cessation of folate supplementation (5 mg/day). Diet supplied 60-80 g protein and 120-260 micrograms folic acid/day. Red cell folate levels decreased linearly from a mean of 1931 +/- 888 micrograms/l (+/- SD) to 676 +/- 294 micrograms/l after 6 months before levelling off at 455 +/- 222 micrograms/l after 9 months. Mean values were unchanged 7 months later (491 +/- 319 micrograms/l). No patient developed folate deficiency. Hemoglobin values at 6, 9 and 16 months were slightly higher than the baseline value of 8.3 +/- 1.8 g/dl (p < 0.05). Mean corpuscular volumes were generally within normal limits, and vitamin B12 status was satisfactory. We conclude that folic acid supplements are unnecessary in adequately nourished hemodialysis patients who are not receiving erythropoietin.
维持性血液透析患者对叶酸膳食补充剂的需求存在争议。高剂量叶酸存在毒性风险且并无必要。我们对一组41例未接受促红细胞生成素治疗的患者在停止叶酸补充(5毫克/天)后进行了16个月的随访。饮食中每日提供60 - 80克蛋白质和120 - 260微克叶酸。红细胞叶酸水平在6个月时从平均1931±888微克/升(±标准差)线性下降至676±294微克/升,9个月后稳定在455±222微克/升。7个月后平均值无变化(491±319微克/升)。无患者出现叶酸缺乏。6个月、9个月和16个月时的血红蛋白值略高于8.3±1.8克/分升的基线值(p<0.05)。平均红细胞体积一般在正常范围内,维生素B12状态良好。我们得出结论,对于未接受促红细胞生成素治疗且营养充足的血液透析患者,无需补充叶酸。